ARTICLE | Clinical News
Theratechnologies regulatory update
June 17, 1996 7:00 AM UTC
TH.B received notice of allowance for a U.S. patent on its TH 9402 photosensitive molecule. TH 9402 is used in the photodynamic treatment of leukemia and cancers affecting the bone marrrow. TH.B. is d...